Tower Research Capital LLC (Trc) Grifols Sa Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Grifols Sa stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,789 shares of GRFS stock, worth $13,989. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,789

Previous 4,671 61.7%

Holding current value

$13,989

Previous $29,000 48.28%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $9.38 $18,098 - $27,033	-2,882 Reduced 61.7%	1,789 $15,000
Q2 2024 Aug 13, 2024	BUY	$6.27 - $7.7 $18,810 - $23,100	3,000 Added 179.53%	4,671 $29,000
Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $5,212 - $10,845	-953 Reduced 36.32%	1,671 $11,000
Q4 2023 Feb 13, 2024	BUY	$7.71 - $11.56 $3,376 - $5,063	438 Added 20.04%	2,624 $30,000
Q3 2023 Nov 14, 2023	SELL	$8.91 - $10.91 $83,148 - $101,812	-9,332 Reduced 81.02%	2,186 $19,000
Q2 2023 Aug 14, 2023	BUY	$7.14 - $9.29 $70,985 - $92,361	9,942 Added 630.84%	11,518 $105,000
Q1 2023 May 09, 2023	SELL	$6.65 - $10.69 $12,462 - $20,033	-1,874 Reduced 54.32%	1,576 $11,000
Q4 2022 Feb 10, 2023	BUY	$5.96 - $8.53 $5,232 - $7,489	878 Added 34.14%	3,450 $29,000
Q3 2022 Nov 10, 2022	BUY	$5.95 - $14.3 $3,064 - $7,364	515 Added 25.04%	2,572 $16,000
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $114,522 - $143,477	-10,804 Reduced 84.01%	2,057 $24,000
Q1 2022 May 12, 2022	BUY	$10.37 - $12.73 $109,735 - $134,708	10,582 Added 464.33%	12,861 $150,000
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $12,742 - $19,056	-1,248 Reduced 35.38%	2,279 $26,000
Q3 2021 Nov 15, 2021	SELL	$14.07 - $17.3 $32,529 - $39,997	-2,312 Reduced 39.6%	3,527 $52,000
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $56,674 - $64,585	3,410 Added 140.39%	5,839 $101,000
Q1 2021 May 17, 2021	SELL	$15.15 - $19.78 $50,055 - $65,353	-3,304 Reduced 57.63%	2,429 $42,000
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $74,639 - $87,079	4,427 Added 338.97%	5,733 $106,000
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $143,712 - $188,133	-9,332 Reduced 87.72%	1,306 $23,000
Q2 2020 Aug 13, 2020	BUY	$18.24 - $21.45 $194,037 - $228,185	10,638 New	10,638 $194,000
Q4 2019 Feb 07, 2020	SELL	$19.57 - $23.52 $526,315 - $632,546	-26,894 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$19.85 - $22.76 $533,845 - $612,107	26,894 New	26,894 $539,000
Q1 2019 May 14, 2019	SELL	$18.01 - $20.11 $10,806 - $12,066	-600 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $17,108 - $21,120	-981 Reduced 62.05%	600 $11,000
Q3 2018 Nov 13, 2018	SELL	$19.97 - $21.96 $31,572 - $34,718	-1,581 Reduced 50.0%	1,581 $34,000
Q2 2018 Aug 15, 2018	BUY	$20.16 - $24.68 $63,745 - $78,038	3,162 New	3,162 $68,000
Q1 2018 May 15, 2018	SELL	$20.31 - $24.95 $1,766 - $2,170	-87 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$20.99 - $23.89 $20 - $23	1 Added 1.16%	87 $2,000
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $1,726 - $1,882	86	86 $2,000

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Grifols Sa Transaction History